A detailed history of Marcum Wealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Marcum Wealth, LLC holds 3,897 shares of NVO stock, worth $436,230. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,897
Previous 3,793 2.74%
Holding current value
$436,230
Previous $541,000 14.23%
% of portfolio
0.04%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$119.07 - $145.42 $12,383 - $15,123
104 Added 2.74%
3,897 $464,000
Q2 2024

Jul 02, 2024

BUY
$122.71 - $146.91 $4,172 - $4,994
34 Added 0.9%
3,793 $541,000
Q1 2024

Apr 10, 2024

SELL
$102.11 - $135.92 $50,136 - $66,736
-491 Reduced 11.55%
3,759 $482,000
Q4 2023

Jan 10, 2024

SELL
$87.78 - $105.45 $12,201 - $14,657
-139 Reduced 3.17%
4,250 $439,000
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $174,786 - $383,515
1,922 Added 77.91%
4,389 $399,000
Q2 2023

Jul 13, 2023

SELL
$155.98 - $172.65 $33,691 - $37,292
-216 Reduced 8.05%
2,467 $399,000
Q1 2023

Apr 19, 2023

BUY
$132.34 - $159.14 $39,702 - $47,741
300 Added 12.59%
2,683 $426,000
Q4 2022

Jan 12, 2023

BUY
$102.55 - $135.33 $3,179 - $4,195
31 Added 1.32%
2,383 $0
Q3 2022

Oct 11, 2022

BUY
$95.28 - $116.93 $381 - $467
4 Added 0.17%
2,352 $234,000
Q2 2022

Jul 14, 2022

BUY
$103.24 - $121.81 $23,848 - $28,138
231 Added 10.91%
2,348 $262,000
Q1 2022

Apr 20, 2022

BUY
$93.1 - $112.54 $10,427 - $12,604
112 Added 5.59%
2,117 $235,000
Q4 2021

Feb 01, 2022

SELL
$95.88 - $117.08 $11,122 - $13,581
-116 Reduced 5.47%
2,005 $225,000
Q3 2021

Nov 08, 2021

BUY
$84.42 - $106.62 $179,054 - $226,141
2,121 New
2,121 $204,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Marcum Wealth, LLC Portfolio

Follow Marcum Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marcum Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marcum Wealth, LLC with notifications on news.